Bill Gates invests in Alzheimer’s research | November 20, 2017 Issue - Vol. 95 Issue 46 | Chemical & Engineering News
Volume 95 Issue 46 | p. 13 | Concentrates
Issue Date: November 20, 2017

Bill Gates invests in Alzheimer’s research

Department: Business
Keywords: Neuroscience, Alzheimer's disease, Bill Gates

Microsoft cofounder Bill Gates has put $50 million into the Dementia Discovery Fund, a venture capital fund that invests in new drugs for Alzheimer’s disease and other forms of dementia. Gates told the news organization Reuters that he will also invest $50 million directly in start-ups researching Alzheimer’s. In his blog, Gates points to the finding that people have a nearly 50% chance of developing the disease if they live into their mid-80s.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment